Evaluation of procalcitonin and CRP as sepsis markers in 74 consecutive patients admitted with prolonged febrile neutropenia

Journal of Infection

Volumn 63, Issue 1, 2011, Pages 93-95

  Cornillon, Jérôme ^a   Bouteloup, Marie ^a   Lambert, Claude ^b  

^a Institut de Cancérologie de la Loire   (France)

^b UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTARABINE; PROCALCITONIN;

BACTEREMIA; BACTERIUM IDENTIFICATION; BONE MARROW TRANSPLANTATION; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; DRUG MEGADOSE; FEBRILE NEUTROPENIA; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LETTER; LEUKEMIA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; PROGNOSIS; PROTEIN BLOOD LEVEL; SEPSIS;

CALCITONIN; FEVER; HUMANS; INFECTION; PROTEIN PRECURSORS;

EID: 79959618958     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.05.010     Document Type: Letter

References (10)

1. Limper M., de Kruif M.D., Duits A.J., Brandjes D.P., van Gorp E.C. The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. J Infect 2010, 60(6):409-416.
2. Hughes W.T., Armstrong D., Bodey G.P., Bow E.J., Brown A.E., Calandra T., et al. Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002, 34(6):730-751.
3. Penack O., Rempf P., Eisenblatter M., Stroux A., Wagner J., Thiel E., et al. Bloodstream infections in neutropenic patients: early detection of pathogens and directed antimicrobial therapy due to surveillance blood cultures. Ann Oncol 2007, 18(11):1870-1874.
4. Sakr Y., Sponholz C., Tuche F., Brunkhorst F., Reinhart K. The role of procalcitonin in febrile neutropenic patients: review of the literature. Infection 2008, 36(5):396-407.
5. Blijlevens N.M., Donnelly J.P., Meis J.F., De Keizer M.H., De Pauw B.E. Procalcitonin does not discriminate infection from inflammation after allogeneic bone marrow transplantation. Clin Diagn Lab Immunol 2000, 7(6):889-892.
6. Ortega M., Rovira M., Filella X., Almela M., Puig de la Bellacasa J., Carreras E., et al. Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation. Br J Haematol 2004, 126(3):372-376.
7. Oberhoffer M., Stonans I., Russwurm S., Stonane E., Vogelsang H., Junker U., et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 1999, 134(1):49-55.
8. Massaro K.S., Costa S.F., Leone C., Chamone D.A. Procalcitonin (PCT) and C-reactive protein (CRP) as severe systemic infection markers in febrile neutropenic adults. BMC Infect Dis 2007, 7:137.
9. Engel A., Steinbach G., Kern P., Kern W.V. Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8. Scand J Infect Dis 1999, 31(2):185-189.
10. Svaldi M., Hirber J., Lanthaler A.I., Mayr O., Faes S., Peer E., et al. Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients. Br J Haematol 2001, 115(1):53-57.